March 5, 2024
GE HealthCare & Vanderbilt publish data on AI models predicting patient response to immunotherapy
The results from a research partnership between GE HealthCare and Vanderbilt University Medical Center utilizing artificial intelligence to enable safer and more precise cancer immunotherapies show that the models they developed predict patient responses with 70% to 80% accuracy.
By Tom Wilemon